-
1Academic Journal
المساهمون: Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was funded by the Institut National de la Santé et de la Recherche Médicale, the Toulouse university, the Fondation de France (R11166BB), the Association pour la Recherche sur le Cancer (PJA 2013 12 00 342), the INCA (PRTK-K15-118), the association « pour Céline » and the association « Flo ».
المصدر: ISSN: 0006-2952.
مصطلحات موضوعية: tesmilifene (PubChem CID: 108092), tamoxifen (PubChem CID: 2733526), 7-dehydrocholesterol (PubChem CID: 439423), 6β-epoxycholesterol (PubChem CID: 108109), 6α-epoxycholesterol (PubChem CID: 227037), 4-hydroxytamoxifen (PubChem CID: 449459), 6-Epoxycholesterol, zymosterol (PubChem CID: 92746), zymostenol (PubChem CID: 101770), toremifene (PubChem CID: 3005573), AEBS, Breast cancer, ICI 164, 684 (PubChem CID: 104772), ICI 182, 780 (PubChem CID: 44307470), MER29, triparanol (PubChem CID: 6536), PBPE (PubChem CID: 71311880), RU 58, 668 (PubChemCID: 119604), Tamoxifen, Zymostenol, bazedoxifene (PubChem CID: 154257), boxidine (PubChem CID: 31742), cholesterol (PubChem CID: 5997), clomiphene (PubChem CID: 1548953), dendrogenin A (PubChem CID: 9806490), desmosterol: (PubChem CID: 439577)
Time: 5
Relation: info:eu-repo/semantics/altIdentifier/pmid/28642035; PUBMED: 28642035
-
2
المساهمون: Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Claudius-Regaud [IUCT-O, Toulouse], Institut Universitaire du Cancer Toulouse - Oncopôle (IUCT), This work was funded by the Institut National de la Santé et de la Recherche Médicale, the Toulouse university, the Fondation de France (R11166BB), the Association pour la Recherche sur le Cancer (PJA 2013 12 00 342), the INCA (PRTK-K15-118), the association « pour Céline » and the association « Flo »., Poirot, Marc, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: Biochemical Pharmacology
Biochemical Pharmacology, Elsevier, 2017, 144, pp.18-28. ⟨10.1016/j.bcp.2017.06.120⟩
Biochemical Pharmacology, 2017, 144, pp.18-28. ⟨10.1016/j.bcp.2017.06.120⟩مصطلحات موضوعية: 0301 basic medicine, 684 (PubChem CID: 104772), Cellular differentiation, [SDV]Life Sciences [q-bio], Estrogen receptor, Pharmacology, Biochemistry, Breast cancer, MER29, Zymostenol, 6α-epoxycholesterol (PubChem CID: 227037), [SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, triparanol (PubChem CID: 6536), [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Cell Death, Chemistry, 6-Epoxycholesterol, Estrogen Antagonists, Cell Differentiation, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, histamine (PubChem CID: 774), RU 58, [SDV] Life Sciences [q-bio], [SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences, ICI 182, zymostenol (PubChem CID: 101770), Cholesterol, Treatment Outcome, Selective estrogen receptor modulator, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, raloxifene (PubChem CID: 5035), Female, dendrogenin A (PubChem CID: 9806490), medicine.drug, Selective Estrogen Receptor Modulators, Programmed cell death, [SDV.SP.MED] Life Sciences [q-bio]/Pharmaceutical sciences/Medication, clomiphene (PubChem CID: 1548953), tamoxifen (PubChem CID: 2733526), Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, lasofoxifene (PubChem CID: 216416), toremifene (PubChem CID: 3005573), AEBS, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, 780 (PubChem CID: 44307470), [SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication, medicine, Autophagy, Animals, Humans, 668 (PubChemCID: 119604), boxidine (PubChem CID: 31742), zymosterol (PubChem CID: 92746), 4-hydroxytamoxifen (PubChem CID: 449459), Lasofoxifene, 17β-estradiol (PubChem CID: 5757), Antiestrogen, Tamoxifen, 030104 developmental biology, ICI 164, 6β-epoxycholesterol (PubChem CID: 108109), desmosterol: (PubChem CID: 439577), [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, 7-dehydrocholesterol (PubChem CID: 439423), tesmilifene (PubChem CID: 108092), bazedoxifene (PubChem CID: 154257), cholesterol (PubChem CID: 5997), [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, PBPE (PubChem CID: 71311880)
وصف الملف: application/pdf